STOCK TITAN

Xenon Pharmaceuticals to Participate at the William Blair Biotech Focus Conference 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Xenon Pharmaceuticals Inc. (Nasdaq:XENE) has announced its upcoming participation in the virtual William Blair Biotech Focus Conference 2021. This event is scheduled for Thursday, July 15, 2021, from 10 am to 10:45 am Eastern Time. Key participants include Ian Mortimer, President and CEO, and Dr. Simon Pimstone, Executive Chair of the Board. For further details and a link to the live webcast, visit Xenon’s official website. Webcasts will be available for replay post-event for 30 days. Xenon is focused on developing innovative therapies for neurological disorders.

Positive
  • None.
Negative
  • None.

BURNABY, British Columbia, July 13, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced its participation in a virtual fireside chat at the William Blair Biotech Focus Conference 2021.

Date:Thursday, July 15, 2021
Time:10 am – 10:45 am Eastern Time
Participants:Ian Mortimer, President and CEO | Dr. Simon Pimstone, Executive Chair of the Board

Additional details along with a link to the live webcast can be found on the “Investors” section of Xenon’s website at http://investor.xenon-pharma.com. When available, webcasts will be posted for replay following the event for 30 days. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Maria McClean
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com


FAQ

When is Xenon Pharmaceuticals participating in the William Blair Biotech Focus Conference 2021?

Xenon Pharmaceuticals will participate in the William Blair Biotech Focus Conference 2021 on Thursday, July 15, 2021, from 10 am to 10:45 am Eastern Time.

Who are the key speakers representing Xenon Pharmaceuticals at the conference?

The key speakers from Xenon Pharmaceuticals at the conference are Ian Mortimer, President and CEO, and Dr. Simon Pimstone, Executive Chair of the Board.

How can I access the live webcast of Xenon's conference participation?

The live webcast of Xenon's participation can be accessed via the 'Investors' section of their official website.

Will there be a replay available for Xenon's conference presentation?

Yes, a replay of the Xenon conference presentation will be available for 30 days after the event.

What is the focus of Xenon Pharmaceuticals?

Xenon Pharmaceuticals is focused on developing innovative therapeutics for neurological disorders, particularly epilepsy.

Xenon Pharmaceuticals Inc

NASDAQ:XENE

XENE Rankings

XENE Latest News

XENE Stock Data

3.14B
74.52M
0.38%
101.18%
3.81%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BURNABY